Thanks. Was kinda what I was thinking without access to testing.
My point here is that as the world begins to understand how this works, the off label use is going to cause manufacturing problems BIG TIME. AVXL will probably have to have a major Pharma partner just to get access to enough certified manufacturing facilities to handle demand. So why not seek a partner now for development and use the proceeds for the pipeline projects that will have smaller indications / patient populations, thus be much more manageable for a smaller company to handle?
News 
Market Data 
Discover 
